[{"Assets_0_Q2_USD":49600076.0,"CommonStockSharesOutstanding_0_Q2_shares":40588004.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14224328.0,"NetIncomeLoss_1_Q2_USD":-5683616.0,"NetIncomeLoss_2_Q2_USD":-14176441.0,"StockholdersEquity_0_Q2_USD":45716480.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]